Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study

Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study

ObjectiveTo explore the clinical efficacy of lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with T4 gastric cancer after surgery and to evaluate its impact on survival.Materials and methodsData on patients with T4 gastric cancer who underwent radical gas...

Full description

Bibliographic Details
Main Authors:	Yuxin Zhong, Wenzhe Kang, Haitao Hu, Weikun Li, Jing Zhang, Yantao Tian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Oncology
Subjects:	gastric cancer lobaplatin hepatic intraperitoneal chemotherapy prognosis advanced
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.995618/full

Similar Items

Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles
by: Zhong Y, et al.
Published: (2020-06-01)

Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles
by: Jing Zhang, et al.
Published: (2023-03-01)

Comparative Study of Short-Term Efficacy and Safety of Mitomycin versus Lobaplatin for Hyperthermic Intraperitoneal Chemotherapy after Radical Surgery in Colorectal Cancer with High-Risk Factors for Peritoneal Carcinomatosis: A Propensity Score Matching Analysis
by: Xikai Guo, et al.
Published: (2023-01-01)

Lobaplatin hyperthermic intraperitoneal chemotherapy plus cytoreduction and rechallenge using cetuximab for wild-type RAS peritoneal metastatic colon cancer: a case report and literature review
by: Peilin Dai, et al.
Published: (2022-02-01)

Efficacy with prognostic value of postoperative prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer
by: SUN Qi, HUANG Wenbo, HE Bingliang, LIU Chang, XU Yuhang, ZHAO Wei
Published: (2023-07-01)

A real-word study: is normothermic intraoperative intraperitoneal chemotherapy impactful as we expect?
by: Mengyao Jin, et al.
Published: (2023-07-01)

Retrospective study of the efficacy and toxicity of lobaplatin‐etoposide chemotherapy in small cell lung cancer
by: Liyan Gu, et al.
Published: (2019-02-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
by: Adriana C. Gamboa, et al.
Published: (2019-10-01)

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma
by: Yan Zheng, et al.
Published: (2021-09-01)

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Jieun Ko, et al.
Published: (2021-09-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer with Peritoneal Metastasis—Indian Experience
by: Somashekhar S.P, et al.
Published: (2022-04-01)

Role of intraperitoneal chemotherapy in gastric cancer
by: Amir Parray, et al.
Published: (2021-03-01)

A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer
by: Lili Liu, et al.
Published: (2022-12-01)

Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery
by: Hsin-Hsien Yu, et al.
Published: (2023-06-01)

Comparative Survival Outcomes of Hyperthermic Intraperitoneal Chemotherapy, Intraperitoneal Chemotherapy and Intravenous Chemotherapy for Primary Advanced Ovarian Cancer: A Network Meta-Analysis
by: Qin Tang, et al.
Published: (2023-01-01)

Complete Response for More than 4 Years following Neoadjuvant FOLFOX and Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Patient with Advanced Gastric Cancer with Extensive Peritoneal Carcinomatosis
by: Renata D’Alpino Peixoto, et al.
Published: (2018-05-01)

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials
by: Sun Jingxu, et al.
Published: (2012-11-01)

Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy
by: Young Song, et al.
Published: (2023-10-01)

Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers
by: Jiyun Hu, et al.
Published: (2023-04-01)

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Carcinomatosis: Additional Information Helps to Optimize Patient Selection before Surgery
by: Hao-Chien Hung, et al.
Published: (2023-03-01)

Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial
by: Maneesh Kumarsing Beeharry, et al.
Published: (2020-03-01)

Hyperthermic Intraperitoneal Chemotherapy and Recirculation with CO<sub>2</sub>: A Safe Technique
by: Remedios Gómez-Sanz, et al.
Published: (2022-10-01)

Drain site enterocutaneous fistula after hyperthermic intraperitoneal chemotherapy
by: Navin Kumar, et al.
Published: (2021-01-01)

Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Maria Consuelo Pintado, et al.
Published: (2023-06-01)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
by: Wei-Chun Chen, et al.
Published: (2022-10-01)

Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report
by: Rob Bielen, et al.
Published: (2013-01-01)

Effect of operation-introducing hyperthermic intraperitoneal chemotherapy on cellular immune function in patients with adenocarcinoma of the esophagogastric junction
by: Zhiyong Nie, et al.
Published: (2022-01-01)

Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
by: Özgül Düzgün, et al.
Published: (2019-09-01)

Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
by: Skierucha Malgorzata, et al.
Published: (2017-12-01)

A Meta-Analysis of Efficacy and Adverse Effects of Lobaplatin and Cisplatin in the Treatment of Malignant Pleural Effusion
by: Shihui MIN, et al.
Published: (2019-02-01)

Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study
by: Lucheng Zhu, et al.
Published: (2020-08-01)

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
by: Wu-yun Wang, et al.
Published: (2021-01-01)

A case report of hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) for malignant peritoneal mesothelioma
by: Hanjian Liu, et al.
Published: (2023-12-01)

Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
by: Hamed Elgendy, et al.
Published: (2019-01-01)

Utility of intraperitoneal hyperthermic chemotherapy in peritoneal cancer from endometrial cancer – literature review
by: Nicolae BACALBASA, et al.
Published: (2017-12-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Loss Martin, et al.
Published: (2004-06-01)

Association between pelvic exenteration and hyperthermic intraperitoneal chemotherapy for rectal cancer
by: Nicolae Bacalbasa, et al.
Published: (2021-06-01)

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy
by: Jingjing Zhang, et al.
Published: (2023-03-01)

Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Patients at High Risk of Developing Gallbladder Cancer Peritoneal Metastases: Case Report and Rationale for a Prospective Clinical Trial
by: Alexander E. Crum, et al.
Published: (2024-01-01)

Hyperthermic Intraperitoneal Chemotherapy: A Critical Review
by: Wim Ceelen, et al.
Published: (2021-06-01)